OKYO
Price:
$1.065
Market Cap:
$36.09M
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.[Read more]
Industry
Biotechnology
IPO Date
2022-05-17
Stock Exchange
NASDAQ
Ticker
OKYO
According to OKYO Pharma Limited’s latest financial reports and current stock price. The company's current ROE is 0.42%. This represents a change of -99.89% compared to the average of 399.61% of the last 4 quarters.
The mean historical ROE of OKYO Pharma Limited over the last ten years is 0.40%. The current 0.42% ROE has changed 7.28% with respect to the historical average. Over the past ten years (40 quarters), OKYO's ROE was at its highest in in the September 2022 quarter at 1.60%. The ROE was at its lowest in in the March 2022 quarter at -97.66%.
Average
0.40%
Median
-1.28%
Minimum
-1471.60%
Maximum
1.10%
Discovering the peaks and valleys of OKYO Pharma Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 1.10%
Minimum Annual Increase = 0%
Minimum Annual ROE = -1471.60%
Year | ROE | Change |
---|---|---|
2024 | 0.29% | -99.96% |
2023 | 646.38% | -450.79% |
2022 | -184.27% | 192.29% |
2021 | -63.04% | -105.71% |
2020 | 1.10% | -174.96% |
2019 | -1471.60% | -Infinity% |
2018 | 0% | 0% |
2017 | 0% | -100.00% |
2016 | -2.56% | -89.48% |
2015 | -24.35% | -17.88% |
The current ROE of OKYO Pharma Limited (OKYO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
154.13%
5-year avg
300.49%
10-year avg
0.40%
OKYO Pharma Limited’s ROE is greater than Bionomics Limited (-116.12%), less than Candel Therapeutics, Inc. (3.21%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Cingulate Inc. (-113174.53%), less than Unicycive Therapeutics, Inc. (0%), greater than Quoin Pharmaceuticals, Ltd. (-374.14%), greater than Cardio Diagnostics Holdings, Inc. (-126.19%), greater than Virax Biolabs Group Limited (-258.81%), greater than PaxMedica, Inc. Common Stock (-115.10%), greater than Senti Biosciences, Inc. (-3167.06%), greater than ZIVO Bioscience, Inc. (-154.84%), less than Cadrenal Therapeutics, Inc. Common Stock (618.61%), greater than Foghorn Therapeutics Inc. (-142.95%), less than Clearmind Medicine Inc. (167.93%), greater than Hillstream BioPharma, Inc. (-211.21%), greater than Coeptis Therapeutics, Inc. (-172.28%), greater than Magenta Therapeutics, Inc. (-225.59%), greater than null (-14.27%),
Company | ROE | Market cap |
---|---|---|
-116.12% | $8.81M | |
3.21% | $391.38M | |
-184.40% | $42.01M | |
-113174.53% | $18.66M | |
0% | $69.56M | |
-374.14% | $2.45M | |
-126.19% | $40.84M | |
-258.81% | $7.47M | |
-115.10% | $696.27K | |
-3167.06% | $19.13M | |
-154.84% | $78.37M | |
618.61% | $24.50M | |
-142.95% | $279.08M | |
167.93% | $7.54M | |
-211.21% | $4.17M | |
-172.28% | $5.84M | |
-225.59% | $42.44M | |
-14.27% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OKYO Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OKYO Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is OKYO Pharma Limited's ROE?
How is the ROE calculated for OKYO Pharma Limited (OKYO)?
What is the highest ROE for OKYO Pharma Limited (OKYO)?
What is the 3-year average ROE for OKYO Pharma Limited (OKYO)?
What is the 5-year average ROE for OKYO Pharma Limited (OKYO)?
How does the current ROE for OKYO Pharma Limited (OKYO) compare to its historical average?